CANTAB

finished pharmaceutical products for the prevention and treatment of human and animal diseases which modulate, activate or suppress the human or animal immune system, specifically restricted to products for the prevention or treatment of autoimmune diseases (rheumatoid arthritis, myasthenia gravis, systemic lupus erythematous, multiple sclerosis), inflammatory diseases (psoriasis, Crohn's disease, ulcerative colitis, asthma, allergic reactions), benign and malignant tumors (genital condylomata and cervical cancer), viral diseases (herpes virus diseases such as oral herpes (HSV 1), genital herpes (HSV 1/2), chicken pox/shingles (varicella zoster virus), cytomegalovirus; respiratory syncytial viruses; measles viruses; human immunodeficiency viruses), microbial and parasitic infections, septic or trauma induced shock and organ transplant rejection